{
 "context": "The following article called 'SolarCity's ABS gets 'A' rating as it moves from S&P to Kroll' was published on 2015-08-14. The body of the article is as follows:\n    \nEnd date SolarCity's ABS gets 'A' rating as it moves from S&P to Kroll \nThe senior tranche of SolarCity's latest asset-backed security (ABS) (link 1) has received an A rating \u2013 higher than any of the company's previous issues.  \n\n    The day before the article was published, the stock price of Akari Therapeutics Plc was 6.400000095367432 and the day after the article was published, the stock price of Akari Therapeutics Plc was ",
 "expected": "6.099999904632568",
 "date": "2015-08-14",
 "ticker": "AKTX",
 "company": "Akari Therapeutics Plc"
}